Normal and Pathophysiological Significance of Myotonic Dystrophy Protein Kinase

Genetic Instabilities and Neurological Diseases

Volumn , Issue , 2006, Pages 79-97

  Wansink, Derick G ^a   van Herpen, René E M A ^a   Wieringa, Bé ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349347208     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369462-1/50006-5     Document Type: Chapter

References (134)

1. Harper P.S. Myotonic Dystrophy 2001, Saunders, London.
2. Fu Y.-H., Pizzuti A., Fenwick R.G., King J., Rajnarayan S., Dunne P.W., Dubel J., Nasser G.A., Ashizawa T., de Jong P., Wieringa B., Korneluk R.G., Perryman M.B., Epstein H.F., Caskey C.T. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255:1256-1258.
3. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J-P., Hudson T., Sohn R., Zemelman B., Snell R.G., Rundle S.A., Crow S., Davies J., Shelbourne P., Buxton J., Jones C., Juvonen V., Johnson K., Harper P.S., Shaw D.J., Housman D.E. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3? end of a transcript encoding a protein kinase family member. Cell 1992, 68:799-808.
4. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Neville C., Narang M., Barcelo J., O'Hoy K., Lebond S., Earle-Macdonald J., de Jong P.J., Wieringa B., Korneluk R.G. Myotonic dystrophy mutation: An unstable CTG repeat in the 3? untranslated region of the gene. Science 1992, 255:1253-1255.
5. Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S.L., Day J.W., Ranum L.P.W. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867.
6. Ranum L.P., Day J.W. Myotonic dystrophy: RNA pathogenesis comes into focus. Am. J. Hum. Genet. 2004, 74:793-804.
7. Amiel J., Trochet D., Clement-Ziza M., Munnich A., Lyonnet S. Polyalanine expansions in human. Hum. Mol. Genet. 2004, 13:R235-R243.
8. Everett C.M., Wood N.W. Trinucleotide repeats and neurodegenerative disease. Brain 2004, 127:2385-2405.
9. Wansink D.G., Wieringa B. Transgenic mouse models for myotonic dystrophy type 1 (DM1). Cytogenet. Genome Res. 2003, 100:230-242.
10. Personius K.E., Nautiyal J., Reddy S. Myotonia and muscle contractile properties in mice with SIX5 deficiency. Muscle Nerve 2005, 31:503-505.
11. Sarkar P.S., Paul S., Han J., Reddy S. Six5 is required for spermatogenic cell survival and spermiogenesis. Hum. Mol. Genet. 2004, 13:1421-1431.
12. Jansen G., Groenen P.J., Bachner D., Jap P.H., Coerwinkel M., Oerlemans F., van den Broek W., Gohlsch B., Pette D., Plomp J.J., Molenaar P.C., Nederhoff M.G., van Echteld C.J., Dekker M., Berns A., Hameister H., Wieringa B. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat. Genet. 1996, 13:316-324.
13. Reddy S., Smith D.B.J., Rich M.M., Leferovich J.M., Reilly P., Davis B.M., Tran K., Rayburn H., Bronson R., Cros D., Balice-Gordon R.J., Housman D. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat. Genet. 1996, 13:325-335.
14. Berul C.I., Maguire C.T., Aronovitz M.J., Greenwood J., Miller C., Gehrmann J., Housman D., Mendelsohn M.E., Reddy S. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J. Clin. Invest. 1999, 103:R1-R7.
15. Klesert T.R., Cho D.H., Clark J.I., Maylie J., Adelman J., Snider L., Yuen E.C., Soriano P., Tapscott S.J. Mice dificient in Six5 develop cataracts: Implications for myotonic dytrophy. Nat. Genet. 2000, 25:105-109.
16. Sarkar P.S., Appukuttan B., Han J., Ito Y., Ai C., Tsai W., Chai Y., Stout J.T., Reddy S. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nat. Genet. 2000, 25:110-114.
17. Schulz P.E., McIntosh A.D., Kasten M.R., Wieringa B., Epstein H.F. A role for myotonic dystrophy protein kinase in synaptic plasticity. J. Neurophysiol. 2003, 89:1177-1186.
18. O'Cochlain D.F., Perez-Terzic C., Reyes S., Kane G.C., Behfar A., Hodgson D.M., Strommen J.A., Liu X.K., van den Broek W., Wansink D.G., Wieringa B., Terzic A. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum. Mol. Genet. 2004, 13:2505-2518.
19. Watchko J.F., O'Day T.L., Hoffman E.P. Functional characteristics of dystrophic skeletal muscle: Insights from animal models. J. Appl. Physiol. 2002, 93:407-417.
20. Durbeej M., Campbell K.P. Muscular dystrophies involving the dystrophin-glycoprotein complex: An overview of current mouse models. Curr. Opin. Genet. Dev. 2002, 12:349-361.
21. Mankodi A., Logigian E., Callahan L., McClain C., White R., Henderson D., Krym M., Thornton C.A. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000, 289:1769-1772.
22. Amack J.D., Mahadevan M.S. Myogenic defects in myotonic dystrophy. Dev. Biol. 2004, 265:294-301.
23. Mankodi A., Teng-Umnuay P., Krym M., Henderson D., Swanson M., Thornton C.A. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann. Neurol. 2003, 54:760-768.
24. Jiang H., Mankodi A., Swanson M.S., Moxley R.T., Thornton C.A. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 2004, 13:3079-3088.
25. Fardaei M., Rogers M.T., Thorpe H.M., Larkin K., Hamshere M.G., Harper P.S., Brook J.D. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet. 2002, 11:805-814.
26. Mankodi A., Urbinati C.R., Yuan Q.P., Moxley R.T., Sansone V., Krym M., Henderson D., Schalling M., Swanson M.S., Thornton C.A. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 2001, 10:2165-2170.
27. Michalowski S., Miller J.W., Urbinati C.R., Paliouras M., Swanson M.S., Griffith J. Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein. Nucleic Acids Res. 1999, 27:3534-3542.
28. Timchenko N.A., Cai Z.J., Welm A.L., Reddy S., Ashizawa T., Timchenko L.T. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem. 2001, 276:7820-7826.
29. Philips A.V., Timchenko L.T., Cooper T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998, 280:737-740.
30. Ho T.H., Charlet B.N., Poulos M.G., Singh G., Swanson M.S., Cooper T.A. Muscleblind proteins regulate alternative splicing. EMBO J. 2004, 23:3103-3112.
31. La Spada A.R., Richards R.I., Wieringa B. Dynamic mutations on the move in Banff. Nat. Genet. 2004, 36:667-670.
32. Ueda H., Ohno S., Kobayashi T. Myotonic dystrophy and myotonic dystrophy protein kinase. Progr. Histochem. Cytochem. 2000, 35:187-251.
33. Groenen P., Wieringa B. Expanding complexity in myotonic dystrophy. Bio Essays 1998, 20:901-912.
34. Lam L.T., Pham Y.C., Nguyen T.M., Morris G.E. Characterization of a monoclonal antibody panel shows that the myotonic dystrophy protein kinase, DMPK, is expressed almost exclusively in muscle and heart. Hum. Mol. Genet. 2000, 9:2167-2173.
35. Pham Y.C., Man N., Lam L.T., Morris G.E. Localization of myotonic dystrophy protein kinase in human and rabbit tissues using a new panel of monoclonal antibodies. Hum. Mol. Genet. 1998, 7:1957-1965.
36. Groenen P.J.T.A., Wansink D.G., Coerwinkel M.van den, Broek W., Jansen G., Wieringa B. Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties. Hum. Mol. Genet. 2000, 9:605-616.
37. van der Ven P.F., Jansen G., van Kuppevelt T.H., Perryman M.B., Lupa M., Dunne P.W., ter Laak H.J., Jap P.H., Veerkamp J.H., Epstein H.F., et al. Myotonic dystrophy kinase is a component of neuromuscular junctions. Hum. Mol. Genet. 1993, 2:1889-1894.
38. Sarkar P.S., Han J., Reddy S. In situ hybridization analysis of Dmpk mRNA in adult mouse tissues. Neuromuscul. Disord. 2004, 14:497-506.
39. Jansen G., Mahadevan M., Amemiya C., Wormskamp N., Segers B., Hendriks W., O'Hoy K., Baird S., Sabourin L., Lennon G.G., Jap P.L., Iles D., Coerwinkel M., Hofker M., Carrano A.V., de Jong P.J., Korneluk R.G., Wieringa B. Characterization of the myotonic dystrophy region predicts multiple protein isoformencoding mRNAs. Nat. Genet. 1992, 1:261-266.
40. Dunne P.W., Ma L., Casey D.L., Harati Y., Epstein H.F. Localization of myotonic dystrophy protein kinase in skeletal muscle and its alteration with disease. Cell Motil. Cytoskeleton 1996, 33:52-63.
41. Furling D., Lam le T., Agbulut O., Butler-Browne G.S., Morris G.E. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy. Am. J. Pathol. 2003, 162:1001-1009.
42. Eriksson M., Hedberg B., Carey N., Ansved T. Decreased DMPK transcript levels in myotonic dystrophy 1 type IIA muscle fibers. Biochem. Biophys. Res. Commun. 2001, 286:1177-1182.
43. Furling D., Lemieux D., Taneja K., Puymirat J. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul. Disord. 2001, 11:728-735.
44. Endo A., Motonaga K., Arahata K., Harada K., Yamada T., Takashima S. Developmental expression of myotonic dystrophy protein kinase in brain and its relevance to clinical phenotype. Acta Neuropathol. (Berlin) 2000, 100:513-520.
45. Balasubramanyam A., Iyer D., Stringer J.L., Beaulieu C., Potvin A., Neumeyer A.M., Avruch J., Epstein H.F. Developmental changes in expression of myotonic dystrophy protein kinase in the rat central nervous system. J. Comp. Neurol. 1998, 394:309-325.
46. Kornblum C., Reul J., Kress W., Grothe C., Amanatidis N., Klockgether T., Schroder R. Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J. Neurol. 2004, 251:710-714.
47. Modoni A., Silvestri G., Pomponi M.G., Mangiola F., Tonali P.A., Marra C. Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1. Arch. Neurol. 2004, 61:1943-1947.
48. Winchester C.L., Ferrier R.K., Sermoni A., Clark B.J., Johnson K.J. Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy. Hum. Mol. Genet. 1999, 8:481-492.
49. Dunne P.W., Ma L., Casey D.L., Epstein H.F. Myotonic protein kinase expression in human and bovine lenses. Biochem. Biophys. Res. Commun. 1996, 225:281-288.
50. Maeda M., Taft C.S., Bush E.W., Holder E., Bailey W.M., Neville H., Perryman M.B., Bies R.D. Identification, tissue-specific expression, and subcellular localization of the 80-and 71-kDa forms of myotonic dystrophy kinase protein. J. Biol. Chem. 1995, 270:20246-20249.
51. Whiting E.J., Waring J.D., Tamai K., Somerville M.J., Hincke M., Staines W.A., Ikeda J.-E., Korneluk R.G. Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous system. Hum. Mol. Genet. 1995, 4:1063-1072.
52. Salvatori S., Biral D., Furlan S., Marin O. Evidence for localization of the myotonic dystrophy protein kinase to the terminal cisternae of the sarcoplasmic reticulum. J. Muscle Res. Cell Motil. 1997, 18:429-440.
53. Mussini I., Biral D., Marin O., Furlan S., Salvatori S. Myotonic dystrophy protein kinase expressed in rat cardiac muscle is associated with sarcoplasmic reticulum and gap junctions. J. Histochem. Cytochem. 1999, 47:383-392.
54. Shimiokawa M., Ishiura S., Kameda N., Yamamoto M., Sasagawa N., Saitoh N., Sorimachi H., Ueda H., Ohno S., Suzuki K., Kobayashi T. Novel isoform of myotonin protein kinase-gene product of myotonic dystrophy is localized in the sarcoplasmic reticulum of skeletal muscle. Am. J. Pathol. 1997, 150:1285-1295.
55. Kameda N., Ueda H., Ohno S., Shimokawa M., Usuki F., Ishiura S., Kobayashi T. Developmental regulation of myotonic dystrophy protein kinase in human muscle cells in vitro. Neuroscience 1998, 85:311-322.
56. van Herpen R.E.M.A., Oude Ophuis R.J.A., Wijers M., Bennink M.B., van de Loo F.A., Fransen J., Wieringa B., Wansink D.G. Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors. Mol. Cell. Biol. 2005, 25:1402-1414.
57. Wansink D.G., van Herpen R.E.M.A., Coerwinkel-Driessen M.M., Groenen P.J.T.A., Hemmings B.A., Wieringa B. Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity and subcellular localization. Mol. Cell. Biol. 2003, 23:5489-5501.
58. Mahadevan M.S., Amemiya C., Jansen G., Sabourin L., Baird S., Neville C.E., Wormskamp N., Segers B., Batzer M., Lamerdin J., de Jong P., Wieringa B., Korneluk R.G. Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene. Hum. Mol. Genet. 1993, 2:299-304.
59. Tiscornia G., Mahadevan M.S. Myotonic dystrophy: The role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRAN isoform ratios. Mol. Cell 2000, 5:959-967.
60. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
61. Caenepeel S., Charydczak G., Sudarsanam S., Hunter T., Manning G. The mouse kinome: Discovery and comparative genomics of all mouse protein kinases. Proc. Natl. Acad. Sci. USA 2004, 101:11707-11712.
62. Ng Y., Tan I., Lim L., Leung T. Expression of the human myotonic dystrophy kinase-related Cdc42-binding kinase is regulated by promoter DNA methylation and Sp1 binding. J. Biol. Chem. 2004, 279:34156-34164.
63. Leung T., Chen X.-Q., Tan I., Manser E., Lim L. Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization. Mol. Cell. Biol. 1998, 18:130-140.
64. Riento K., Ridley A.J. Rocks: Multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol. 2003, 4:446-456.
65. Madaule P., Eda M., Watanabe N., Fujisawa K., Matsuoka T., Bito H., Ishizaki T., Narumiya S. Role of citron kinase as a target of the small GTPase Rho in cytokinesis. Nature 1998, 394:491-494.
66. Zhao Z.S., Manser E. PAK and other Rho-associated kinases: Effectors with surprisingly diverse mechanisms of regulation. Biochem. J. 2005, 2:201-214.
67. Tan I., Seow K.T., Tim L., Leung T. Intermolecular and intramolecular interactions regulate catalytic activity-of myotonic dystrophy kinase-related Cdc42-binding kinase ?. Mol. Cell. Biol. 2001, 21:2767-2778.
68. Doran J.D., Liu X., Taslimi P., Saadat A., Fox T. New insights into the structure-function relationships of Rho-associated kinase: A thermodynamic and hydrodynamic study of the dimer-to-monomer transition and its kinetic implications. Biochem. J. 2004, 384:255-262.
69. Zhang R., Epstein H.F. Homodimerization through coiled-coil regions enhances activity of the myotonic dystrophy protein kinase. FEBS Lett. 2003, 546:281-287.
70. Bush E.W., Helmke S.M., Birnbaum R.A., Perryman M.B. Myotonic dystrophy protein kinase domains mediate localization, oligomerization, novel catalytic activity, and autoinhibition. Biochemistry 2000, 39:8480-8490.
71. Hanks S.K., Hunter T. The eukaryotic protein kinase superfamily: Kinase (catalytic) domain structure and classification. FASEB J. 1995, 9:576-596.
72. Nolen B., Taylor S., Ghosh G. Regulation of protein kinases: Controlling activity through activation segment conformation. Mol. Cell 2004, 15:661-675.
73. Krupa A., Preethi G., Srinivasan N. Structural modes of stabilization of permissive phosphorylation sites in protein kinases: Distinct strategies in Ser/Thr and Tyr kinases. J. Mol. Biol. 2004, 339:1025-1039.
74. Huse M., Kuriyan J. The conformational plasticity of protein kinases. Cell 2002, 109:275-282.
75. Johnson L.N., Noble M.E., Owen D.J. Active and inactive protein kinases: Structural basis for regulation. Cell 1996, 85:149-158.
76. Adams J.A. Activation loop phosphorylation and catalysis in protein kinases: Is there functional evidence for the autoin-hibitor model?. Biochemistry 2003, 42:601-607.
77. Waring J.D., Haq R., Tamai K., Sabourin L.A., Ikeda J.-E., Korneluk R.G. Investigation of myotonic dystrophy kinase isoform translocation and membrane association. J. Biol. Chem. 1996, 271:15187-15193.
78. Timchenko L., Nastainczyk W., Schneider T., Patel B., Hofmann F., Caskey C.T. Full-length myotonin protein kinase (72 kDa) displays serine kinase activity. Proc. Natl. Acad. Sci. USA 1995, 92:5366-5370.
79. Dunne P.W., Walch E.T., Epstein H.F. Phosphorylation reactions of recombinant human myotonic dystrophy protein kinase and their inhibition. Biochemistry 1994, 33:10809-10814.
80. Yang J., Cron P., Thompson V., Good V.M., Hess D., Hemmings B.A., Barford D. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell 2002, 9:1227-1240.
81. Biondi R.M., Nebreda A.R. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem. J. 2003, 372:1-13.
82. Frodin M., Antal T.L., Dummler B.A., Jensen C.J., Deak M., Gammeltoft S., Biondi R.M. A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J. 2002, 21:5396-5407.
83. Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307:1098-1101.
84. Gao T., Furnari F., Newton A.C. PHLPP: A phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 2005, 18:13-24.
85. Millward T.A., Heizmann C.W., Schafer B.W., Hemmings B.A. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J. 1998, 17:5913-5922.
86. Turner M.S., Fen Fen L., Trauger J.W., Stephens J., LoGrasso P. Characterization and purification of truncated human Rho-kinase II expressed in Sf-21 cells. Arch. Biochem. Biophys. 2002, 405:13-20.
87. Obata T., Yaffe M.B., Leparc G.G., Piro E.T., Maegawa H., Kashiwagi A., Kikkawa R., Cantley L.C. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J. Biol. Chem. 2000, 275:36108-36115.
88. Millward T.A., Hess D., Hemmings B.A. Ndr protein kinase is regulated by phosphorylation on two conserved sequence motifs. J. Biol. Chem. 1999, 274:33847-33850.
89. Muranyi A., Zhang R., Liu F., Hirano K., Ito M., Epstein H.F., Hartshorne D.J. Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity. FEBS Lett. 2001, 493:80-84.
90. Amano M., Chihara K., Nakamura N., Kaneko T., Matsuura Y., Kaibuchi K. The COOH terminus of Rho-kinase negatively regulates Rho-kinase activity. J. Biol. Chem. 1999, 274:32418-32424.
91. Rost B. Did evolution leap to create the protein universe?. Curr. Opin. Struct. Biol. 2002, 12:409-416.
92. Burkhard P., Stetefeld J., Strelkov S.V. Coiled coils: A highly versatile protein folding motif. Trends Cell Biol. 2001, 11:82-88.
93. Lupas A. Coiled coils: New structures and new functions. Trends Biochem. Sci. 1996, 21:375-382.
94. Mason J.M., Arndt K.M. Coiled-coil domains: Stability, specificity, and biological implications. Chem Bio Chem 2004, 5:170-176.
95. Shimizu T., Ihara K., Maesaki R., Amano M., Kaibuchi K., Hakoshima T. Parallel coiled-coil association of the RhoA-binding domain in Rho-kinase. J. Biol. Chem. 2003, 278:46046-46051.
96. Borgese N., Colombo S., Pedrazzini E. The tale of tail-anchored proteins: Coming from the cytosol and looking for a membrane. J. Cell Biol. 2003, 161:1013-1019.
97. High S., Abell B.M. Tail-anchored protein biosynthesis at the endoplasmic reticulum: The same but different. Biochem. Soc. Trans. 2004, 32:659-662.
98. Takada S., Shirakata Y., Kaneniwa N., Koike K. Association of hepatitis B virus X protein with mitochondria, causes mitochondrial aggregation at the nuclear periphery, leading to cell death. Oncogene 1999, 18:6965-6973.
99. i signaling dynamics and metabolism by perinuclear mitochondria in mouse parotid acinar cells. J. Biol. Chem. 2004, 279:12909-12917.
100. Amano M., Fukata Y., Kaibuchi K. Regulation and functions of Rho-associated kinase. Exp. Cell Res. 2000, 261:44-51.
101. Mounsey J.P., Xu P., John J.E., Horne L.T., Gilbert J., Roses A.D., Moorman J.R. Modulation of skeletal, muscle sodium channels by human myotonin protein kinase. J. Clin. Invest. 1995, 95:2379-2384.
102. Chahine M., George A.L. Myotonic dystrophy kinase modulates skeletal muscle but not cardiac voltage-gated sodium channels. FEBS Lett. 1997, 412:621-624.
103. Mistry D.J., Moorman J.R., Reddy S., Mounsey J.P. Skeletal muscle Na currents in mice heterozygous for Six5 deficiency. Physiol. Genom. 2001, 6:153-158.
104. Mounsey J.P., Mistry D.J., Ai C.W., Reddy S., Moorman J.R. Skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. Hum. Mol. Genet. 2000, 9:2313-2320.
105. Lee H.C., Patel M.K., Mistry D.J., Wang Q., Reddy S., Moorman J.R., Mounsey J.P. Abnormal Na channel gating in murine cardiac myocytes deficient in myotonic dystrophy protein kinase. Physiol. Genom. 2003, 12:147-157.
106. Reddy S., Mistry D.J., Wang Q.C., Geddis L.M., Kutchai H.C., Moorman J.R., Mounsey J.P. Effects of age and gene dose on skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. Muscle Nerve 2002, 25:850-857.
107. Jacobs A.E., Benders A.A., Oosterhof A., Veerkamp J.H., van Mier P., Wevers R.A., Joosten E.M. The calcium homeostasis and the membrane potential of cultured muscle cells from patients with myotonic, dystrophy. Biochim. Biophys. Acta 1990, 1096:14-19.
108. 2+ homeostasis in skeletal muscle cells. J. Clin. Invest. 1997, 100:1440-1447.
109. Kaliman P., Catalucci D., Lam J.T., Kondo R., Gutierrez J.C.P., Reddy S., Palacin M., Zorzano A., Chien K.R., Ruiz-Lozano P. Myotonic dystrophy protein kinase (DMPK) phosphorylates phospholamban and regulates calcium uptake in cardiomyocyte sarcoplasmic reticulum. J. Biol. Chem. 2005, 280:8016-8021.
110. Mounsey J.P., John J.E., Helmke S.M., Bush E.W., Gilbert J., Roses A.D., Perryman M.B., Jones L.R., Moorman J.R. Phospholemman is a substrate for myotonic dystrophy protein kinase. J. Biol. Chem. 2000, 275:23362-23367.
111. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature 2002, 420:629-635.
112. Shimizu M., Wang W., Walch E.T., Dunne P.W., Epstein H.F. Rac-1 and Raf-1 kinases, components of, distinct signaling pathways, activate myotonic dystrophy protein kinase. FEBS Lett. 2000, 475:273-277.
113. Jin S., Shimizu M., Balasubramanyam A., Epstein H.F. Myotonic dystrophy protein kinase (DMPK) induces actin cytoskeletal reorganization and apoptotic-like blebbing in lens cells. Cell Motil. Cytoskeleton 2000, 45:133-148.
114. Sasagawa N., Kino Y., Takeshita Y., Oma Y., Ishiura S. Overexpression of human myotonic dystrophy protein kinase in Schizosaccharomyces pombe induces an abnormal polarized and swollen cell morphology. J. Biochem. (Tokyo) 2003, 134:537-542.
115. Piekny A.J., Mains P.E. Rho-binding kinase (LET-502) and myosin phosphatase (MEL-11) regulate cytokinesis in the early Caenorhabditis elegans embryo. J. Cell Sci. 2002, 115:2271-2282.
116. Yamashiro S., Totsukawa G., Yamakita Y., Sasaki Y., Madaule P., Ishizaki T., Narumiya S., Matsumura F. Citron kinase, a rho-dependent kinase induces di-phosphorylation of regulatory light chain of myosin II. Mol. Biol. Cell 2003, 14:1745-1756.
117. Hartshorne D.J., Ito M., Erdodi F. Role of protein phosphatase type 1 in contractile functions: Myosin phosphatase. J. Biol. Chem. 2004.
118. 2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 2003, 83:1325-1358.
119. Yang X., Yu K., Hao Y., Li D.M., Stewart R., Insogna K.L., Xu T. LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nat. Cell Biol. 2004, 6:609-617.
120. Samstag Y., Nebl G. Interaction of cofilin with the serine phosphatases PP1 and PP2A in normal and neoplastic human T lymphocytes. Adv. Enzyme Regul. 2003, 43:197-211.
121. Wilkinson S., Paterson H.F., Marshall C.J. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat. Cell Biol. 2005, 7:255-261.
122. Iyer D., Belaguli N., Fluck M., Rowan B.G., Wei L., Weigel N.L., Booth F.W., Epstein H.F., Schwartz R.J., Balasubramanyam A. Novel phosphorylation target in the serum response factor MADS box regulates alpha-actin transcription. Biochemistry 2003, 42:7477-7486.
123. n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc. Natl. Acad. Sci. USA 1997, 94:13221-13226.
124. Savkur R.S., Philips A.V., Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 2001, 29:40-47.
125. Ladd A.N., Charlet-B.N., Cooper T.A. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 2001, 21:1285-1296.
126. Timchenko N.A., Patel R., Iakova P., Cai Z.-J., Quan L., Timchenko L.T. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J. Biol. Chem. 2004, 279:13129-13139.
127. Ho T.H., Bundman D., Armstrong D.L., Cooper T.A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet. 2005, 14:1539-1547.
128. Suzuki A., Sugiyama Y., Hayashi Y., Nyu-i N., Yoshida M., Nonaka I., Ishiura S., Arahata K., Ohno S. MKBP, a novel member of the small heat shock protein family, binds and activates the myotonic dystrophy protein kinase. J. Cell Biol. 1998, 140:1113-1124.
129. Shimizu Y., Thumkeo D., Keel J., Ishizaki T., Oshima H., Oshima M., Noda Y., Matsumura F., Taketo M.M., Narumiya S. ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles. J Cell Biol. 2005, 168:941-953.
130. Thumkeo D., Keel J., Ishizaki T., Hirose M., Nonomura K., Oshima H., Oshima M., Taketo M.M., Narumiya S. Targeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death. Mol. Cell. Biol. 2003, 23:5043-5055.
131. Di Cunto F., Imarisio S., Hirsch E., Broccoli V., Bulfone A., Migheli A., Atzori C., Turco E., Triolo R., Dotto G.P., Silengo L., Altruda F. Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis. Neuron 2000, 28:115-127.
132. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
133. Letunic I., Copley R.R., Schmidt S., Ciccarelli F.D., Doerks T., Schultz J., Ponting C.P., Bork P. SMART 4.0: Towards genomic data integration. Nucleic Acids Res. 2004, 32:D142-D144.
134. Lupas A., Van Dyke M., Stock J. Predicting coiled coils from protein sequences. Science 1991, 252:1162-1164.